AzTrials
AzTrials

Dental CariesSDF-FVNCT07153328

SDF With or Without Fluoride Varnish for Caries Arrest in Primary Teeth of Young Children

A study testing Silver Diamine Fluoride (SDF, 38%) and Sodium Fluoride Varnish (NaF, 5%) and Silver Diamine Fluoride (SDF, 38%) in people with Dental Caries, run by Beaty Dent at 2 sites in Albania.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Tooth decay (dental caries) occurs when acids dissolve tooth structure. If not treated, cavities in primary teeth can progress quickly, leading to caries, infection and early tooth loss. These problems may affect chewing, speech, nutrition, and overall health. Read more about this study

Who is it for?
Ages 18 months to 8 years
Conditions the study is for
Dental Caries
What is being tested?
Silver Diamine Fluoride (SDF, 38%) and Sodium Fluoride Varnish (NaF, 5%) and Silver Diamine Fluoride (SDF, 38%)
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
104 participants
Where
2 sitesAlbania
Study dates
7 Jan 2021to 25 Mar 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 months to 8 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children aged 1.5 to 8 years
  • Uncooperative to dental procedures (Frankl Behavior Rating 1 or 2)
  • Presence of at least one active, cavitated carious lesion in primary teeth, without pulp involvement
  • Eligible primary teeth: active caries without pulp involvement

Who cannot join

  • Children with clinical signs of infection (pain, parulis, fistula, or abscess)
  • Cooperative to dental procedures
  • Children who are candidates for conscious sedation
  • Known allergy to silver, fluoride, or ammonia
  • Teeth with pulpal complications, non-restorable, exfoliating, or scheduled for extraction

Trial locations and contacts

2 sites in 1 country.

Albania2 sites
  • Beaty Dent

    Tirana, Tirana, 1001

  • Happy Dent

    Tirana, Tirana, 1001

Other trials in Albania

About this study

Official title: Silver Diamine Fluoride in Arresting Dental Caries Among Young Children, a Randomized Clinical Trial

Tooth decay (dental caries) occurs when acids dissolve tooth structure. If not treated, cavities in primary teeth can progress quickly, leading to caries, infection and early tooth loss. These problems may affect chewing, speech, nutrition, and overall health. In Albania and many other countries, cavities in young children are very common. Standard dental treatments are often difficult in very young or uncooperative children and may require sedation or general anesthesia.

Silver diamine fluoride (SDF) is a liquid medication that can be painted directly onto cavities. SDF stops cavities from worsening by killing bacteria and hardening softened tooth surfaces. The main side effect is dark staining of the treated area. Despite this, SDF is considered safe and effective, especially for children who cannot tolerate conventional treatment. Fluoride varnish (FV) is another preventive treatment applied to all tooth surfaces to strengthen enamel and help prevent new cavities.

Read more

The purpose of this study is to compare two approaches for managing tooth decay in young children who have difficulty cooperating for dental care:

  • SDF applied to cavities every six months.
  • SDF applied every six months, with FV applied to all teeth every three months. A total of 104 children between the ages of 1.5 and 8 years with active cavities in their primary (baby) teeth were enrolled. Children were randomly assigned to one of the two treatment groups.

The children were followed for 24 months. The main outcome measured is whether cavities became arrested, meaning the surface became hard and inactive with no further breakdown. Additional outcomes include whether combining SDF with FV provides added benefit and whether baseline factors such as oral hygiene and diet influence treatment success.

The information from this study may help dentists and parents understand how SDF, with or without FV, can be used as a safe, effective, and child-friendly option to manage cavities in young children.

Read the detailed description

Dental caries is a biofilm-mediated disease driven by dietary sugars and bacterial acid production. The prevalence in primary dentition is high worldwide, especially in low- and middle-income countries. Conventional restorative treatments are difficult to perform in very young or behaviorally uncooperative children, and may require sedation or general anesthesia. Therefore, minimally invasive methods such as silver diamine fluoride (SDF) have gained importance as a practical option for arresting active caries lesions.

Rationale and Objectives SDF (38%) is a topical solution with antimicrobial and remineralizing properties that has been shown to arrest dentin caries in children. A limitation is that it stains carious surfaces black. Fluoride varnish (5% NaF) is widely used as a preventive agent to reduce new caries formation. Combining the two may offer dual benefits: SDF for arresting existing lesions and varnish for preventing new ones. The objective of this randomized clinical trial was to compare the effectiveness of two protocols-SDF alone versus alternating SDF and fluoride varnish-for arresting dentin caries in uncooperative young children with primary teeth.

Study Design This was a two-arm, parallel-group, randomized controlled clinical trial conducted in a pediatric dental setting. A total of 104 children aged 1.5-8 years with at least one active dentin caries lesion in primary teeth were enrolled and randomized in a 1:1 ratio. Children with systemic conditions contraindicating participation were excluded. Informed consent was obtained from parents or guardians, and the protocol was approved by the national ethics committee.

Interventions

Group 1 (SDF only): Lesions received 38% SDF application every 6 months.

Group 2 (SDF + FV): Lesions received 38% SDF application every 6 months, with 5% NaF varnish applied to all teeth every 3 months.

All treatments were delivered by calibrated operators according to standardized protocols. Oral hygiene and dietary advice were given to caregivers.

Outcome Measures

Primary outcome: Caries arrest at 24 months, defined as hardening of the lesion surface with no further progression, assessed visually and tactually by blinded examiners.

Secondary outcomes:

Comparative efficacy between the two protocols

Incidence of new caries in non-treated teeth

Influence of baseline factors (oral hygiene, sugar intake, socioeconomic status) on treatment outcomes

Adverse effects, including pulp symptoms and parental acceptance of staining

Follow-up and Data Collection Clinical examinations were performed at baseline, 6, 12, 18, and 24 months. Standardized diagnostic criteria were used. Lesion depth and activity were recorded, and intra-examiner reliability was periodically tested. Caregivers were interviewed about oral health behaviors. Data were entered into an electronic database with quality control checks.

Statistical Analysis Descriptive statistics were used to summarize baseline characteristics. Caries arrest rates were compared between groups using mixed-effects logistic regression to account for clustering of multiple surfaces within each child. Effect modification by baseline covariates (oral hygiene, sugar intake, socioeconomic status, lesion depth) was tested through interaction terms. Statistical significance was set at p < 0.05. Analyses were performed using Stata software.

Safety and Monitoring SDF and fluoride varnish are approved topical agents for dental use and have well-established safety profiles. Adverse events were monitored and reported. No independent Data Monitoring Committee was appointed given the minimal risk nature of the interventions.

Expected Impact This trial provides comparative evidence on two practical, non-invasive caries management protocols in uncooperative pediatric patients. The findings may inform public health strategies and clinical guidelines for the management of early childhood caries in similar populations.

Conditions
Dental Caries
Being tested
Silver Diamine Fluoride (SDF, 38%) and Sodium Fluoride Varnish (NaF, 5%), Silver Diamine Fluoride (SDF, 38%)
Medical subject headings
Dental Caries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Silver Diamine Fluoride (SDF, 38%) and Sodium Fluoride Varnish (NaF, 5%)Drug

    Also called Saforide (Toyo Seiyaku Kasei, Japan), Advantage Arrest (Elevate Oral Care, USA), Riva Star (SDI, Australia), 3M™ Fast Release Varnish, Duraphat (Colgate), CavityShield (3M), Flor-Opal (Ultradent)

    Application of 38% silver diamine fluoride (SDF) to all active carious lesions at baseline and every 6 months (months 0, 6, 12, and 18, 24). In addition, a 5% sodium fluoride varnish (NaF) is applied to all teeth at 3-month intervals (months 3, 9, 15, 21). Applications are performed by a dentist using standard microbrush or applicator techniques, ensuring lesions coverage for SDF and full dentition coverage for NaF varnish. This alternating protocol evaluates whether combining periodic SDF with regular fluoride varnish enhances caries arrest in primary teeth compared to semiannual SDF alone.

  • Silver Diamine Fluoride (SDF, 38%)Drug

    Also called Saforide (Toyo Seiyaku Kasei Co., Japan), Advantage Arrest (Elevate Oral Care, USA), Riva Star (SDI Limited, Australia) 3M™ Fast Release Varnish, Duraphat (Colgate-Palmolive), CavityShield

    Application of 38% silver diamine fluoride (SDF) to all active carious lesions at baseline and every 6 months (months 0, 6, 12, and 18, 24). Applications are performed by a dentist using a microbrush to directly cover the lesion surface until fully saturated. No additional fluoride varnish is provided in this arm. The protocol evaluates the effectiveness of semiannual SDF application alone for arresting active caries in primary teeth of young, uncooperative pediatric patients.

Study groups in NCT07153328
Study groupRoleWhat they receive
Semiannual 38% Silver Diamine Fluoride (SDF)ExperimentalParticipants assigned to this arm receive topical application of 38% silver diamine fluoride (SDF) to all active carious lesions at baseline and every 6 months (months 0, 6, 12, and 18, 24). In addition, a 5% sodium fluoride varnish (NaF) is applied to all teeth at 3-month intervals (months 3, 9, 15, 21). Applications are performed by a dentist using standard microbrush or applicator techniques, ensuring lesions coverage for SDF and full dentition coverage for NaF varnish. This alternating protocol evaluates whether combining periodic SDF with regular fluoride varnish enhances caries arrest in primary teeth compared to semiannual SDF alone.
Receives: Drug: Silver Diamine Fluoride (SDF, 38%) and Sodium Fluoride Varnish (NaF, 5%); Drug: Silver Diamine Fluoride (SDF, 38%)
Alternating 38% SDF + 5% Sodium Fluoride Varnish (FV)Active comparatorParticipants assigned to this arm receive topical application of 38% silver diamine fluoride (SDF) to all active carious lesions at baseline and every 6 months (months 0, 6, 12, and 18, 24). Applications are performed by a dentist using a microbrush to directly cover the lesion surface until fully saturated. No additional fluoride varnish is provided in this arm. The protocol evaluates the effectiveness of semiannual SDF application alone for arresting active caries in primary teeth of young, uncooperative pediatric patients.
Receives: Drug: Silver Diamine Fluoride (SDF, 38%) and Sodium Fluoride Varnish (NaF, 5%)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Caries arrest rate of treated lesions

    Proportion of active carious lesions that transition to a hardened, non-progressive state (surface hardness on probing, dark discoloration, no cavitation/enlargement), assessed by visual-tactile examination using ICDAS-based criteria under proper lighting and dry conditions. Evaluations conducted by blinded assessors.

    Measured: Baseline, 6, 12, 18, and 24 months post-treatment

Secondary outcomes (1)
  1. Progression of treated lesions to advanced caries or pulpal complications

    Proportion of treated surfaces exhibiting progression defined as softened dentin upon probing or development of pulpal complications (pain, parulis/fistula, tenderness to percussion). Lesions meeting failure criteria are withdrawn from arrest analysis and managed according to standard protocols.

    Measured: 6, 12, 18, and 24 months post-treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Sep 2025
  2. Study start7 Jan 2021
  3. Primary completion25 Mar 2024
  4. Study completion25 Mar 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants were randomized into two parallel groups: (1) semiannual application of 38% silver diamine fluoride (SDF) to active lesions, or (2) an alternating protocol of 38% SDF applied to active lesions and 5% sodium fluoride varnish (FV) applied to all teeth every three months. Participants remained in their assigned group for the 24-month follow-up period.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
104 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07153328
Sponsor's protocol ID
SDF-FV-TRIAL-2021-2022
Other IDs
SDF-FV-TRIAL-2021-2022
Acronym
SDF-FV
Status last verified
Aug 2025
First submitted
16 Aug 2025
Last updated
3 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data (IPD) will not be shared because the study involves pediatric patients, where data protection and confidentiality are paramount. Only aggregate results will be reported in publications.

Publications

  • Duangthip D, Wong MCM, Chu CH, Lo ECM. Caries arrest by topical fluorides in preschool children: 30-month results. J Dent. 2018 Mar;70:74-79. doi: 10.1016/j.jdent.2017.12.013. Epub 2017 Dec 28.

    PubMed 29289726
  • Trieu A, Mohamed A, Lynch E. Silver diamine fluoride versus sodium fluoride for arresting dentine caries in children: a systematic review and meta-analysis. Sci Rep. 2019 Feb 14;9(1):2115. doi: 10.1038/s41598-019-38569-9.

    PubMed 30765785
  • Abdellatif EB, El Kashlan MK, El Tantawi M. Silver diamine fluoride with sodium fluoride varnish versus silver diamine fluoride in arresting early childhood caries: a 6-months follow up of a randomized field trial. BMC Oral Health. 2023 Nov 17;23(1):875. doi: 10.1186/s12903-023-03597-5.

    PubMed 37978488
  • Chu CH, Lo EC, Lin HC. Effectiveness of silver diamine fluoride and sodium fluoride varnish in arresting dentin caries in Chinese pre-school children. J Dent Res. 2002 Nov;81(11):767-70. doi: 10.1177/0810767.

    PubMed 12407092

Questions about this trial

What is this clinical trial studying?

A study testing Silver Diamine Fluoride (SDF, 38%) and Sodium Fluoride Varnish (NaF, 5%) and Silver Diamine Fluoride (SDF, 38%) in people with Dental Caries, run by Beaty Dent at 2 sites in Albania.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Albania. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Caries arrest rate of treated lesions (time frame: Baseline, 6, 12, 18, and 24 months post-treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07153328, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Sep 2025; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in